PT76808A - Process for preparing a culture medium suitable for a method for determining the nutritional status of lymphocytes - Google Patents

Process for preparing a culture medium suitable for a method for determining the nutritional status of lymphocytes

Info

Publication number
PT76808A
PT76808A PT76808A PT7680883A PT76808A PT 76808 A PT76808 A PT 76808A PT 76808 A PT76808 A PT 76808A PT 7680883 A PT7680883 A PT 7680883A PT 76808 A PT76808 A PT 76808A
Authority
PT
Portugal
Prior art keywords
lymphocytes
preparing
determining
culture medium
medium suitable
Prior art date
Application number
PT76808A
Other languages
English (en)
Inventor
William Shive
Original Assignee
Clayton Found Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clayton Found Res filed Critical Clayton Found Res
Publication of PT76808A publication Critical patent/PT76808A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT76808A 1982-06-03 1983-06-01 Process for preparing a culture medium suitable for a method for determining the nutritional status of lymphocytes PT76808A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38482282A 1982-06-03 1982-06-03
US06/492,308 US4499064A (en) 1982-06-03 1983-05-06 Assessment of nutritional status of individuals

Publications (1)

Publication Number Publication Date
PT76808A true PT76808A (en) 1983-07-01

Family

ID=27010775

Family Applications (1)

Application Number Title Priority Date Filing Date
PT76808A PT76808A (en) 1982-06-03 1983-06-01 Process for preparing a culture medium suitable for a method for determining the nutritional status of lymphocytes

Country Status (18)

Country Link
US (1) US4499064A (pt)
EP (1) EP0096560B1 (pt)
KR (1) KR890000729B1 (pt)
AU (1) AU560934B2 (pt)
CA (1) CA1199883A (pt)
DE (1) DE3371362D1 (pt)
DK (1) DK172418B1 (pt)
ES (1) ES522980A0 (pt)
FI (1) FI77470C (pt)
GB (1) GB2124366B (pt)
HK (1) HK90188A (pt)
IE (1) IE55162B1 (pt)
IL (1) IL68873A (pt)
MX (1) MX161244A (pt)
NO (1) NO164252C (pt)
NZ (1) NZ204471A (pt)
PT (1) PT76808A (pt)
SG (1) SG57287G (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208039A (en) * 1985-12-19 1993-05-04 Centre National De La Recherche Scientifique (Cnrs) Nutrient compositions deprived of methionine and supplemented with homocysteine
GB8900924D0 (en) * 1989-01-17 1989-03-08 Amco Chemie Handel Compositions for use in enzyme deficiencies
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US5985665A (en) * 1996-06-19 1999-11-16 Research Development Foundation Biochemical analysis of antioxidant function of lymphocytes in culture
TW517089B (en) 1996-09-03 2003-01-11 Res Dev Foundation Assessment of intracellular cysteine and glutathione concentrations
AU4195899A (en) * 1998-05-21 1999-12-06 Roger Davis Deutsch Patient-controlled lymphocyte method for detecting nutrient deficiency
US7136820B1 (en) * 1999-11-22 2006-11-14 Advanced Medical Instruments Method/process of determining a personal dietary supplement profile and recommending dietary supplements for an individual
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
WO2002085297A2 (en) * 2001-04-24 2002-10-31 East Carolina University Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
US6723527B2 (en) 2001-10-26 2004-04-20 Board Of Regents, The University Of Texas System Methods for determining toxicity reversing agents
AU2003269889B2 (en) * 2002-06-17 2007-04-19 Epigenesis Pharmaceuticals, Llc Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
US7405207B2 (en) * 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090263381A1 (en) * 2003-07-31 2009-10-22 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
US20090285899A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20090297611A1 (en) * 2003-07-31 2009-12-03 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026884A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) * 2003-07-31 2005-02-24 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050026881A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050113318A1 (en) * 2003-07-31 2005-05-26 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
EP1824516A4 (en) * 2004-10-29 2008-11-05 Target Discovery Inc GLYCAN ANALYSIS WITH DEUTERATED GLUCOSE
WO2006127761A1 (en) * 2005-05-26 2006-11-30 Pediatrix Medical Group, Inc. Nutrition formulations and methods of providing nutrition formulations
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
CN101780083B (zh) * 2009-01-16 2012-01-25 海南四环医药有限公司 一种亚叶酸钙与苯丙氨酸的组合物及其制备方法
US20100210582A1 (en) * 2009-02-18 2010-08-19 Stewart Kendal L Method and composition for treating patients with a high risk of developing neuro-immune disorders or developmental delays, identified through the utilization of low homocysteine or its precursors/metabolites, as the predictor of such risk
LT2837680T (lt) 2011-07-01 2020-07-10 Amgen Inc. Žinduolių ląstelių kultūra
MX2020011614A (es) 2018-05-01 2020-12-09 Amgen Inc Anticuerpos con perfiles de glicanos modulados.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US309985A (en) * 1884-12-30 Milk-can
US3128228A (en) * 1960-03-04 1964-04-07 Ustav Ser A Ockovacich Latek Tissue culture medium
US4282326A (en) * 1978-10-12 1981-08-04 Jeanne Moldenhauer Cell culture medium supplement
US4302437A (en) * 1979-08-30 1981-11-24 Victor Herbert Mitogen stimulated lymphocyte transformation
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell

Also Published As

Publication number Publication date
FI77470C (fi) 1989-03-10
GB2124366B (en) 1986-11-12
SG57287G (en) 1987-09-18
AU560934B2 (en) 1987-04-30
IL68873A (en) 1987-03-31
AU1536483A (en) 1983-12-08
US4499064A (en) 1985-02-12
NZ204471A (en) 1987-08-31
NO164252C (no) 1990-09-12
FI77470B (fi) 1988-11-30
KR840005012A (ko) 1984-11-03
DK254383A (da) 1983-12-04
NO164252B (no) 1990-06-05
HK90188A (en) 1988-11-18
IL68873A0 (en) 1983-10-31
ES8405953A1 (es) 1984-06-16
FI832005A0 (fi) 1983-06-03
IE831322L (en) 1983-12-03
GB8315287D0 (en) 1983-07-06
NO831985L (no) 1983-12-05
DK254383D0 (da) 1983-06-03
KR890000729B1 (ko) 1989-03-30
EP0096560B1 (en) 1987-05-06
IE55162B1 (en) 1990-06-20
EP0096560A1 (en) 1983-12-21
FI832005L (fi) 1983-12-04
CA1199883A (en) 1986-01-28
ES522980A0 (es) 1984-06-16
DE3371362D1 (en) 1987-06-11
DK172418B1 (da) 1998-06-02
MX161244A (es) 1990-08-24
GB2124366A (en) 1984-02-15

Similar Documents

Publication Publication Date Title
PT76808A (en) Process for preparing a culture medium suitable for a method for determining the nutritional status of lymphocytes
IL70145A0 (en) Method for producing an article with a fluid passage
EG15419A (en) Process for preparing azabicyclooctane-carboxylic acids
GB2070598B (en) Process for preparing 3-iodomethyl cephalosporins
PL249671A1 (en) Process for preparing cephalosporins
DE3368181D1 (en) Whey fermentation process
JPS57194920A (en) Method and machine for changing carton into solid
PL238624A1 (en) Process for preparing aspartase
GB2144118B (en) Method for preparing 4-methylionone
JPS57110252A (en) Method for making material asceptic
DE3360014D1 (en) Process for preparing 2-methoxyalkanoic acids
BG37227A1 (en) Method for preparing beta- lactamic acids
DE3362454D1 (en) Process for preparing 1-hydroxy-alkane-1-phosphonic acids
DE3162444D1 (en) Process for preparing amidinecarboxylic acids
PL242747A1 (en) Process for preparing novel cephalosporins
PL242191A2 (en) Process for preparing 1-aminoalkanophosphonic acids
PL244702A1 (en) Process for preparing novel n-aminosalicylophosphonic acids
BG49226A1 (en) Method for preparing carnitindehydrogenase
GB8325721D0 (en) Supplement for culture media
BG35062A1 (en) Method for preparing monomineral products
IL88570A0 (en) Process for producing l-lysine
HUT34157A (en) Process for preparing new azetidinyl-acetic acids
PT74227A (en) Process for preparing d(-) p-hidroxyphenylglycine
BG36987A1 (en) Method for preparing gamma- ferrous oxyhydroxide
PL240060A2 (en) Process for preparing alpha-amino-omega-phosphonocarboxylic acids